Radiopharmaceutical company, Cyclopharm Limited (ASX:CYC) today announced financial report for the six month period to 30 June 2020, including sales revenue of $5.8 million, in line with previous guidance, and a 0.5 cents per share dividend.
Key features of the financial results for the 2020 half year include...
For more information, download the attached PDF.
Download this document
